Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Current ESC guidelines assign a Class I recommendation to GLP-1RAs for patients with type 2 diabetes and established cardiovascular disease
Solution: Read labels carefully
Linus Pauling Institute Oregon State University Updated in November 2004 by: Jane Higdon, Ph.D
:max_bytes(150000):strip_icc()/HEALTH-DWL-frame-final-4-83ab587c91ea4eab9e89a0e86add8e41.jpg)
The decision framework: if your all-in cost with insurance (including time spent on prior auth and appeals) exceeds your cost with compounded medication, and you're comfortable with compounded medication's regulatory status, the compounded route is rational
US$ 22.08
US$ 26.52
US$ 27.22
US$ 22.55
US$ 26.46
US$ 24.92
